Pre-order Enquiry
Request Free Sample
2020-2025 Global High Throughput Screening Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
SKU ID : Maia-17106016 | Publishing Date : 07-Jan-2021 | No. of pages : 109
Request Sample
Request Customization
Check Discounts
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is characterized by trace, fast, sensitive and accurate. In short, you can get a lot of information in one experiment and find valuable information from it.
This report elaborates the market size, market characteristics, and market growth of the High Throughput Screening industry, and breaks down according to the type, application, and consumption area of High Throughput Screening. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for High Throughput Screening in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global High Throughput Screening market covered in Chapter 13:
Merck KGaA
Corning Inc.
Becton
Charles River Laboratories International Inc.
PerkinElmer Inc.
Tecan Group Ltd.
Eurofins Scientific SE
Dickinson and Co.
AstraZeneca Plc
Sartorius AG
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Beckman Coulter Inc.
Danaher Corp.
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.
In Chapter 6, on the basis of types, the High Throughput Screening market from 2015 to 2025 is primarily split into:
Instruments
Reagents and Kits
Services
In Chapter 7, on the basis of applications, the High Throughput Screening market from 2015 to 2025 covers:
Drug Discovery
Chemical Biology Programs
Cell- & Organ-Based Screening
Biochemical Screening
Biological Active Compound Screening
Genomics
Proteomics
Compound Profiling
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the High Throughput Screening industry, and breaks down according to the type, application, and consumption area of High Throughput Screening. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for High Throughput Screening in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global High Throughput Screening market covered in Chapter 13:
Merck KGaA
Corning Inc.
Becton
Charles River Laboratories International Inc.
PerkinElmer Inc.
Tecan Group Ltd.
Eurofins Scientific SE
Dickinson and Co.
AstraZeneca Plc
Sartorius AG
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Beckman Coulter Inc.
Danaher Corp.
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.
In Chapter 6, on the basis of types, the High Throughput Screening market from 2015 to 2025 is primarily split into:
Instruments
Reagents and Kits
Services
In Chapter 7, on the basis of applications, the High Throughput Screening market from 2015 to 2025 covers:
Drug Discovery
Chemical Biology Programs
Cell- & Organ-Based Screening
Biochemical Screening
Biological Active Compound Screening
Genomics
Proteomics
Compound Profiling
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
